Press Releases

PMV Pharmaceuticals to Present Rezatapopt Pivotal Phase 2 Initial Analysis and Natural History Study Results at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Oral presentation to highlight initial data from ongoing pivotal Phase 2 study of rezatapopt, a first-in-class precision oncology investigational therapy, in patients with advanced solid tumors harboring a TP53 Y220C mutation PRINCETON, N.J., Oct....

Milestone® Pharmaceuticals to Present Data on Etripamil at the American Heart Association Scientific Sessions 2025

MONTREAL and CHARLOTTE, N.C., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced...

Phthalate Risk Evaluation under TSCA: B&C’s October 30 Webinar Explores Potential Impacts to the Plastics Industry

B&C is pleased to present a complimentary webinar that will explore the status of EPA’s precedent-setting review of seven phthalates under TSCA Section 6. WASHINGTON, DC, UNITED STATES, October 8, 2025 /⁨EINPresswire.com⁩/ -- Bergeson & Campbell,...

WEST PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into West Pharmaceutical Services, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In West Pharmaceuticals (WST) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in West between February 16,...

Brain & Behavior Research Foundation Awards 2025 Outstanding Achievement Prizes to Five Leading Psychiatric Researchers

New York, Oct. 08, 2025 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF), the world’s largest private funder of mental health research grants, today announced it is awarding the 2025 Outstanding Achievement Prizes in Mental...

Mobilicom Launches Secured AutonomyTM: Industry’s First Comprehensive Cybersecurity Framework for Autonomous Drones and Robotics

Expands Mobilicom’s addressable markets with growing portfolio of partnered solutions that integrate the Company’s cybersecurity software into partners’ next-generation AI-driven hardware and software solutions to deliver safe and secure...

Michael Thomas Hair Design Reopens as Naples’ Luxury Hair Wellness Salon, Where Health, Science, and Artistry Unite

Owner and master stylist Christina Thompson unveils a new era of beauty in Naples where health, science, and beauty meet. Collier Chamber to host ribbon-cutting NAPLES, FL, UNITED STATES, October 7, 2025 /⁨EINPresswire.com⁩/ -- Michael Thomas Hair...

Auron Therapeutics to Participate in the 8th Annual Targeted Protein Degradation & Induced Proximity Summit

NEWTON, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced that members of its...

4DMT Advances 4D-710 to Phase 2 with Additional Funding and Support from the Cystic Fibrosis Foundation

Cystic Fibrosis Foundation to provide up to $11 million in additional funding to accelerate development of 4D-710 for cystic fibrosis, following program and clinical data review by its independent scientific advisors Funding supports second 4D-710...

Bluejay Therapeutics Announces Data Presentations in Chronic Hepatitis D (CHD) and Chronic Hepatitis B (CHB) at Upcoming American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2025

REDWOOD CITY, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing therapeutics for serious viral and liver diseases, today announced...

Avacta to Present First Dual Payload pre|CISION® Medicines Data at the 2025 EORTC-NCI-AACR International Conference on Molecular Targets Symposium

LONDON and PHILADELPHIA, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, ‘Avacta’, ‘the Company’), a clinical stage biopharmaceutical company developing pre|CISION®, a unique oncology delivery platform, today announces that the...

CervoMed Appoints Matthew Winton, Ph.D., as Chief Commercial and Business Officer

BOSTON, Oct. 07, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today announced the appointment of Matthew Winton,...

Bionano to Participate in the H.C. Wainwright @ Home Event

SAN DIEGO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will participate in the H.C. Wainwright @ Home Event on Wednesday, October...

Biomed Valley Discoveries Announces Publication of Results from Phase 1b Study of Pembrolizumab in Combination with Clostridium novyi-NT (CNV-NT/BVD-550) in Patients with Advanced Solid Tumors in Clinical Cancer Research

Led by researchers at MD Anderson Cancer Center, the study demonstrated an overall objective response rate of 25% (n=4) among patients with various solid tumor types BVD is advancing CNV-NT, an attenuated form of the Clostridium novyi bacteria...

Bowman Acquires Sierra Overhead Analytics, Expands Technology-enabled Engineering Services

RESTON, Va., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Bowman Consulting Group Ltd. (NASDAQ: BWMN), a national engineering services and project management firm, today announced it has acquired the assets of California-based Sierra Overhead Analytics...

Berger Montague PC Investigating Claims on Behalf of Cepton, Inc. (NASDAQ: CPTN) Investors After Class Action Filing

PHILADELPHIA, Oct. 13, 2025 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against Cepton, Inc. (NASDAQ: CPTN) (“Cepton” or the “Company”) on behalf of investors who purchased or sold Cepton...

CymSTAR Secures U.S. Air Force C-5 Training System Contract Valued at $150M+

BROKEN ARROW, OK, UNITED STATES, October 6, 2025 /⁨EINPresswire.com⁩/ -- CymSTAR, a premier integrator of aircrew and maintenance training systems, has been awarded a contract valued at more than $150 million by the U.S. Air Force to continue...

D’Art Powers Immersive Retail Rollouts for India’s Appliance Brands

D’Art transforms consumer appliance retail with immersive design, tech integration, and consistent rollouts for leading Indian brands. DELHI, INDIA, September 30, 2025 /⁨EINPresswire.com⁩/ -- The Indian consumer electronics and home appliances...

Mobilicom Launches Secured Autonomy™ Framework: A Common Structure for Cybersecurity in Autonomous Systems

Introduces a unified cybersecurity framework and technical primer to help secure autonomous drones and robotics across global operations WASHINGTON, DC, UNITED STATES, October 13, 2025 /⁨EINPresswire.com⁩/ -- Mobilicom Ltd., a provider of...

FDA Online Controlled Substances Summit, Washington, D.C. - 09/11/2025

Speech by Grace Graham Deputy Commissioner for Policy, Legislation, and International Affairs - Food and Drug Administration Good afternoon. On behalf of the FDA, I am pleased to welcome you to the sixth Online Controlled Substances Summit. Thank...